NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
Welbilt, Inc. (NYSE: WBT)
Class Period: February 24, 2017 - November 2, 2018
Lead Plaintiff Deadline: February 11, 2019
Join the action: https://www.zlk.com/pslra-1/welbilt-inc-loss-form?wire=3
Allegations: Welbilt, Inc. made materially false and/or misleading statements throughout the class period and/or failed to
disclose that: (i) the Company lacked effective internal control over financial reporting; (ii) the Company was incorrectly
recording the tax basis of foreign subsidiaries and the amortization of their intangible assets; and (iii) as a result of the
foregoing, Defendants’ statements about Welbilt’s business, operations, and prospects, were false and misleading and/or lacked a
reasonable basis. On November 5, 2018, Welbilt filed a Form 8-K for its Q3 2018, stating that “During the third quarter of
2018, the Company identified errors in the tax basis of a foreign subsidiary and incorrect amortization of the intangible assets
held by the same entity… In addition, the Company discovered certain intercompany transactions were not recorded on a timely
basis.” As a result of these errors, Welbilt announced that “the consolidated financial statements of the Company as of and for the
year ended December 31, 2016 will be restated, and as of and for the years ended December 31, 2015 and 2017 are expected to be
revised.”
To learn more about the Welbilt, Inc. class action contact jlevi@levikorsinsky.com.
Nissan Motor Co., Ltd. (OTCMKTS: NSANY)
Class Period: December 10, 2013 - November 16, 2018
Lead Plaintiff Deadline: February 8, 2019
Join the action: https://www.zlk.com/pslra-1/nissan-motor-co-ltd-loss-form?wire=3
Allegations: Nissan Motor Co., Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) for
more than a decade, Nissan had been materially understating its costs--and thus overstating profits--by paying a material portion
of Ghosn’s executive compensation in the form of billions of Yen of deferred compensation that the Company was concealing from its
public financial reports; (2) in so doing, Nissan was concealing from investors significant defects in its corporate governance;
(3) Nissan’s overpayment of defendant Ghosn had caused it to exceed its shareholder-approved executive pay cap, thus threatening
its continued stock listing; (4) Nissan lacked effective internal and reporting controls; and (5) as a result, defendants’
statements about Nissan’s business metrics, operations, and financial prospects were materially false and misleading and/or lacked
a reasonable basis at all relevant times.
To learn more about the Nissan Motor Co., Ltd. class action contact jlevi@levikorsinsky.com.
Tenaris S.A. (NYSE: TS)
Class Period: May 1, 2014 - November 27, 2018
Lead Plaintiff Deadline: February 11, 2019
Join the action: https://www.zlk.com/pslra-1/tenaris-s-a-loss-form?wire=3
Allegations: During the class period, Tenaris S.A. made materially false and/or misleading statements and/or failed to disclose
that: (1) Tenaris’s CEO and Chairman, Paolo Rocca, knew that one of his company’s executives paid cash to government officials from
2009 to 2012 to expedite compensation payments for the sale of Sidor; (2) this conduct would lead to Rocca being charged in a graft
scheme, and subject Tenaris, its affiliates, and/or executives to heightened governmental scrutiny; and (3) as a result, Tenaris’s
public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the
lawsuit claims that investors suffered damages.
To learn more about the Tenaris S.A. class action contact jlevi@levikorsinsky.com.
Teladoc Health, Inc. (NYSE: TDOC)
Class Period: March 3, 2016 - December 5, 2018
Lead Plaintiff Deadline: February 11, 2019
Join the action: https://www.zlk.com/pslra-1/teladoc-health-inc-loss-form?wire=3
Allegations: Teladoc Health, Inc. made materially false and/or misleading statements throughout the class period and/or failed
to disclose that: (i) Executive Vice President and Chief Operating Officer Mark Hirschhorn was engaged in an inappropriate sexual
relationship with a subordinate; (ii) Hirschhorn and this subordinate engaged in insider trading to provide themselves with undue
benefits; (iii) Hirschhorn caused the subordinate to receive promotions for which she was unqualified, thereby negatively impacting
the Company’s operations; (iv) the Company’s enforcement of its own purported employment and trading policies were inadequate to
prevent the foregoing conduct; and (v) as a result, the Company’s public statements were materially false and misleading at all
relevant times.
To learn more about the Teladoc Health, Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
